Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
Haematologica|April 27, 2023
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammationTomoya Muto, Callum S Walker, Puneet Agarwal, et al.Nature Communications|October 25, 2024
Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosisAshley E Culver-Cochran, Aishlin Hassan, Kathleen Hueneman, et al.Nature Immunology|April 22, 2020
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCsTomoya Muto, Callum S Walker, Kwangmin Choi, et al.Cell Reports|February 27, 2020
TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant HematopoiesisMadeline Niederkorn, Kathleen Hueneman, Kwangmin Choi, et al.Blood Advances|December 3, 2024
TIFAB modulates metabolic pathways in KMT2A::MLLT3-induced AML through HNF4AYang Wang, Yan Xiu, Qianze Dong, et al.Iscience|May 24, 2024
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AMLLaura Barreyro, Avery M Sampson, Kathleen Hueneman, et al.The Journal of Clinical Investigation|September 14, 2011
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerDaniel T Starczynowski, William W Lockwood, Sophie Deléhouzée, et al.Nature Medicine|June 14, 2016
A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromesJing Fang, Xiaona Liu, Lyndsey Bolanos, et al.Blood|October 22, 2010
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterationsDaniel T Starczynowski, Ryan Morin, Andrew McPherson, et al.Haematologica|May 30, 2013
Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesisFukun Guo, Shuangmin Zhang, Matthew Grogg, et al.Pageof 9